LAUSR

FGFR2 Inhibition in Cholangiocarcinoma.

Sign Up to like & get
recommendations!
1 Published in 2022 at "Annual review of medicine"

DOI: 10.1146/annurev-med-042921-024707

Abstract: Biliary tract cancer (BTC) is the second most common primary liver cancer after hepatocellular carcinoma and accounts for 2% of cancer-related deaths. BTCs are classified according to their anatomical origin into intrahepatic (iCCA), perihilar, or… read more here.

Keywords: inhibition cholangiocarcinoma; icca; fgfr2 inhibition; medicine ... See more keywords